Evidence map›Paper›PMID 31615963›Full record

ArticlemBio2019

Combination of Proteogenomics with Peptide

B Blank-Landeshammer, I Teichert, R Märker, M Nowrousian, U Kück, A Sickmann

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Plants (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

B Blank-LandeshammerLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.
I TeichertAllgemeine und Molekulare Botanik, Ruhr-Universität, Bochum, Germany.ORCID 0000-0002-2993-6756
R MärkerAllgemeine und Molekulare Botanik, Ruhr-Universität, Bochum, Germany.
M NowrousianAllgemeine und Molekulare Botanik, Ruhr-Universität, Bochum, Germany.ORCID 0000-0003-0075-6695
U KückAllgemeine und Molekulare Botanik, Ruhr-Universität, Bochum, Germany ulrich.kueck@rub.de albert.sickmann@isas.de.
A SickmannLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany ulrich.kueck@rub.de albert.sickmann@isas.de.
Ruhr University Bochum · DELeibniz Institute for Analytical Sciences - ISAS · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteogenomics combines proteomics, genomics, and transcriptomics and has considerably improved genome annotation in poorly investigated phylogenetic groups for which homology information is lacking. Furthermore, it can be advantageous when reinvestigating well-annotated genomes. Here, we applied an advanced proteogenomics approach, combining standard proteogenomics with peptide

Indexed as

Alternative SplicingGenome, FungalMolecular Sequence AnnotationPeptidesPhylogenyProteogenomicsPeptidesalternative splice sitesalternative splicingfungal genomegene ontologygenomicspeptide de novo sequencingphylostratigraphyproteogenomicsproteomicsRNA editing

Identifiers

PMID31615963
PMCPMC6794485
OpenAlexW2981119379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.